The table below shows C4 Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$35.95M
$35.58M
$20.76M
$31.10M
$45.78M
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$104.24M
$110.64M
$117.71M
$117.84M
$94.67M
$78.44M
SG&A
$36.20M
CCCC annual revenue (10-K history)
C4 Therapeutics, Inc. reported annual revenue of $35.95M for fiscal year 2025. That is up 1.0% from $35.58M in fiscal 2024. Over the 5 fiscal years shown, annual revenue declined from $45.78M (FY 2021) to $35.95M. Figures come from the company's audited annual reports as filed with the SEC.